These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12021629)

  • 21. Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults.
    Yacobi A; Lampman T; Levy G
    Clin Pharmacol Ther; 1977 Mar; 21(3):283-6. PubMed ID: 837646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling.
    Jun H; Rong Y; Yih C; Ho J; Cheng W; Kiang TKL
    Drugs R D; 2020 Dec; 20(4):343-358. PubMed ID: 33026608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical response in epilepsy in relation to total and free serum levels of phenytoin.
    Peterson GM; Khoo BH; von Witt RJ
    Ther Drug Monit; 1991 Sep; 13(5):415-9. PubMed ID: 1957333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.
    ter Heine R; van Maarseveen EM; van der Westerlaken MM; Braun KP; Koudijs SM; Berg MJ; Malingré MM
    J Child Neurol; 2014 Jun; 29(6):803-10. PubMed ID: 23670246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying patients who might benefit from free phenytoin monitoring.
    Baird-Lambert J; Manglick MP; Wall M; Buchanan N
    Ther Drug Monit; 1987 Jun; 9(2):134-8. PubMed ID: 3303467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model.
    Ter Heine R; Kane SP; Huitema ADR; Krasowski MD; van Maarseveen EM
    Br J Clin Pharmacol; 2019 Oct; 85(10):2360-2368. PubMed ID: 31269540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.
    Hong JM; Choi YC; Kim WJ
    Yonsei Med J; 2009 Aug; 50(4):517-20. PubMed ID: 19718399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of glycated albumin on phenytoin binding in elderly patients with type II diabetes mellitus.
    Kostic BA; Olsen KM; Kearns GL; Kemp SF
    Pharmacotherapy; 1990; 10(5):362-5. PubMed ID: 2235672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenytoin-oxacillin interactions in normal and uremic sera.
    Dasgupta A; Sperelakis A; Mason A; Dean R
    Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography.
    Chen J; Ohnmacht C; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):137-45. PubMed ID: 15282104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between serum and salivary phenytoin concentrations in Thai epileptic children.
    Liamsuwan S; Jaiweerawattana U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S172-7. PubMed ID: 22043772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A graphical nomogram method for predicting toxic concentrations of unbound phenytoin.
    Pospisil J; Pelclová D
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):122-5. PubMed ID: 8205372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation.
    Soriano VV; Tesoro EP; Kane SP
    Ann Pharmacother; 2017 Aug; 51(8):669-674. PubMed ID: 28470115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum phenytoin levels of patients on gastrostomy tube feeding.
    Faraji B; Yu PP
    J Neurosci Nurs; 1998 Feb; 30(1):55-9. PubMed ID: 9604823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
    Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
    Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenytoin protein binding in pediatric patients with acute traumatic injury.
    Griebel ML; Kearns GL; Fiser DH; Woody RC; Turley CP
    Crit Care Med; 1990 Apr; 18(4):385-91. PubMed ID: 1969339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary free concentrations of anti-epileptic drugs: an evaluation in a routine clinical setting.
    al Za'abi M; Deleu D; Batchelor C
    Acta Neurol Belg; 2003 Mar; 103(1):19-23. PubMed ID: 12704979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.